National Institute on Deafness and Other Communication Disorders
Overview
The National Institute on Deafness and Other Communication Disorders (NIDCD) is a component of the U.S. National Institutes of Health (NIH). Its mission is to conduct and support biomedical and behavioral research and research training in the normal and disordered processes of hearing, balance, smell, taste, voice, speech, and language. The institute funds research through grants, career development awards, training awards, and contracts to public and private research institutions.
Portfolio Companies
15
Website
nidcd.nih.govInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Advanced Optronics | Jun 2025 | Grant | Co-investor |
| Qualia Oto | Jun 2026 | Grant | Co-investor |
| Oricula Therapeutics | Apr 2014 | Grant | Lead |
| Audiance Inc. | Mar 2021 | Grant | Co-investor |
| OmniSpeech | Nov 2015 | Grant | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is National Institute on Deafness and Other Communication Disorders based?
National Institute on Deafness and Other Communication Disorders is headquartered in Bethesda, Maryland, United States.
When was National Institute on Deafness and Other Communication Disorders founded?
Founding year information for National Institute on Deafness and Other Communication Disorders is not publicly available.
How many portfolio companies does National Institute on Deafness and Other Communication Disorders have?
National Institute on Deafness and Other Communication Disorders has 15 portfolio companies in Caplight's dataset.
What are some companies in National Institute on Deafness and Other Communication Disorders's portfolio?
Portfolio companies visible on Caplight include Advanced Optronics, Qualia Oto, Oricula Therapeutics, Audiance Inc., OmniSpeech.
What was National Institute on Deafness and Other Communication Disorders's most recent investment shown here?
National Institute on Deafness and Other Communication Disorders's most recent investment in this portfolio sample was in Qualia Oto in 2026.
What sectors does National Institute on Deafness and Other Communication Disorders focus on?
National Institute on Deafness and Other Communication Disorders focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Enterprise Software, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Consumer & Commerce, Frontier & Industrial Tech.
What company stages does National Institute on Deafness and Other Communication Disorders focus on?
National Institute on Deafness and Other Communication Disorders typically invests at the MultiStage stage.
What is National Institute on Deafness and Other Communication Disorders's AUM?
National Institute on Deafness and Other Communication Disorders's assets under management are estimated between $535.9M and $535.9M.